BIESF
Price
$32.00
Change
+$1.52 (+4.99%)
Updated
Mar 10 closing price
Capitalization
1.59B
SOLTF
Price
$6.60
Change
+$0.80 (+13.79%)
Updated
Jun 26 closing price
Capitalization
544.22M
Interact to see
Advertisement

BIESF vs SOLTF

Header iconBIESF vs SOLTF Comparison
Open Charts BIESF vs SOLTFBanner chart's image
Biotest AG
Price$32.00
Change+$1.52 (+4.99%)
Volume$100
Capitalization1.59B
Nxera Pharma
Price$6.60
Change+$0.80 (+13.79%)
Volume$1.5K
Capitalization544.22M
BIESF vs SOLTF Comparison Chart in %
Loading...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIESF vs. SOLTF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIESF is a Buy and SOLTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BIESF: $32.00 vs. SOLTF: $6.60)
Brand notoriety: BIESF and SOLTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIESF: 100% vs. SOLTF: 294%
Market capitalization -- BIESF: $1.59B vs. SOLTF: $544.22M
BIESF [@Biotechnology] is valued at $1.59B. SOLTF’s [@Biotechnology] market capitalization is $544.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIESF’s FA Score shows that 1 FA rating(s) are green whileSOLTF’s FA Score has 0 green FA rating(s).

  • BIESF’s FA Score: 1 green, 4 red.
  • SOLTF’s FA Score: 0 green, 5 red.
According to our system of comparison, BIESF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 6 TA indicator(s) are bullish.

  • SOLTF’s TA Score: 6 bullish, 2 bearish.

Price Growth

BIESF (@Biotechnology) experienced а 0.00% price change this week, while SOLTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIESF($1.59B) has a higher market cap than SOLTF($544M). SOLTF YTD gains are higher at: 7.186 vs. BIESF (4.987).
BIESFSOLTFBIESF / SOLTF
Capitalization1.59B544M293%
EBITDA88.9MN/A-
Gain YTD4.9877.18669%
P/E Ratio43.70N/A-
Revenue707MN/A-
Total Cash37.8MN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BIESF vs SOLTF: Fundamental Ratings
BIESF
SOLTF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
5787
PRICE GROWTH RATING
1..100
5753
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
3038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIESF's Valuation (52) in the null industry is somewhat better than the same rating for SOLTF (85). This means that BIESF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

BIESF's Profit vs Risk Rating (67) in the null industry is somewhat better than the same rating for SOLTF (100). This means that BIESF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

BIESF's SMR Rating (57) in the null industry is in the same range as SOLTF (87). This means that BIESF’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's Price Growth Rating (53) in the null industry is in the same range as BIESF (57). This means that SOLTF’s stock grew similarly to BIESF’s over the last 12 months.

BIESF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for SOLTF (100). This means that BIESF’s stock grew significantly faster than SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIESFSOLTF
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
33%
Stochastic
ODDS (%)
N/A
Bullish Trend 5 days ago
41%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
5%
Bullish Trend 5 days ago
33%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
6%
Bullish Trend 5 days ago
31%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
22%
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGFRX13.320.17
+1.29%
William Blair Growth R6
WPASX54.760.60
+1.11%
AB Concentrated Growth A
JEDTX17.770.16
+0.91%
Janus Henderson Global Sust Eq D
OSCYX23.160.14
+0.61%
Invesco Main Street Small Cap Y
LCEVX18.770.11
+0.59%
Invesco Diversified Dividend C

BIESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIESF has been loosely correlated with PTGX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if BIESF jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIESF
1D Price
Change %
BIESF100%
N/A
PTGX - BIESF
66%
Loosely correlated
+0.71%
MLYS - BIESF
45%
Loosely correlated
+1.68%
TRVI - BIESF
42%
Loosely correlated
+4.39%
ZURA - BIESF
40%
Loosely correlated
+0.89%
SOLTF - BIESF
35%
Loosely correlated
N/A
More

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
XTLB - SOLTF
24%
Poorly correlated
+10.00%
SLRN - SOLTF
23%
Poorly correlated
N/A
SPHRF - SOLTF
22%
Poorly correlated
N/A
PRTG - SOLTF
20%
Poorly correlated
-3.08%
More